Capital Counsel’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-339,630
| Closed | -$60.2M | – | 53 |
|
|
2022
Q1 | $60.2M | Sell |
339,630
-17,116
| -5% | -$2.91M | 2.86% | 12 |
|
|
2021
Q4 | $61M | Sell |
356,746
-219,675
| -38% | -$36M | 2.59% | 13 |
|
|
2021
Q3 | $93.1M | Sell |
576,421
-8,505
| -1% | -$1.45M | 4.58% | 10 |
|
|
2021
Q2 | $96.4M | Buy |
584,926
+11,206
| +2% | +$1.86M | 4.84% | 10 |
|
|
2021
Q1 | $94.3M | Buy |
573,720
+8,185
| +1% | +$1.32M | 5.25% | 10 |
|
|
2020
Q4 | $89M | Buy |
565,535
+19,300
| +4% | +$2.85M | 5.21% | 9 |
|
|
2020
Q3 | $81.3M | Buy |
546,235
+6,967
| +1% | +$1.03M | 5.49% | 9 |
|
|
2020
Q2 | $75.8M | Buy |
539,268
+57,318
| +12% | +$8.35M | 5.51% | 9 |
|
|
2020
Q1 | $63.2M | Buy |
481,950
+41,585
| +9% | +$5.9M | 5.02% | 9 |
|
|
2019
Q4 | $64.2M | Sell |
440,365
-39,574
| -8% | -$5.37M | 4.27% | 11 |
|
|
2019
Q3 | $62.1M | Buy |
479,939
+34,687
| +8% | +$4.57M | 4.35% | 10 |
|
|
2019
Q2 | $62M | Buy |
445,252
+4,320
| +1% | +$598K | 4.15% | 11 |
|
|
2019
Q1 | $61.6M | Buy |
440,932
+198
| +0% | +$26.5K | 4.5% | 10 |
|
|
2018
Q4 | $56.9M | Sell |
440,734
-7,130
| -2% | -$995K | 4.72% | 10 |
|
|
2018
Q3 | $61.9M | Sell |
447,864
-5,511
| -1% | -$732K | 4.32% | 11 |
|
|
2018
Q2 | $55M | Buy |
453,375
+3,225
| +0.7% | +$402K | 4.2% | 11 |
|
|
2018
Q1 | $57.7M | Buy |
450,150
+8,107
| +2% | +$1.1M | 4.67% | 11 |
|
|
2017
Q4 | $61.8M | Buy |
442,043
+2,365
| +0.5% | +$329K | 5.08% | 9 |
|
|
2017
Q3 | $57.2M | Buy |
439,678
+44,533
| +11% | +$5.9M | 5.12% | 9 |
|
|
2017
Q2 | $52.3M | Buy |
395,145
+81,766
| +26% | +$10.4M | 4.76% | 8 |
|
|
2017
Q1 | $39M | Buy |
313,379
+14,180
| +5% | +$1.69M | 3.72% | 9 |
|
|
2016
Q4 | $34.5M | Buy |
299,199
+284,217
| +1,897% | +$32.8M | 3.56% | 9 |
|
|
2016
Q3 | $1.77M | Sell |
14,982
-80
| -0.5% | -$9.71K | 0.16% | 28 |
|
|
2016
Q2 | $1.83M | Sell |
15,062
-15,400
| -51% | -$1.75M | 0.17% | 29 |
|
|
2016
Q1 | $3.3M | Sell |
30,462
-59,185
| -66% | -$6.13M | 0.3% | 25 |
|
|
2015
Q4 | $9.21M | Sell |
89,647
-7,718
| -8% | -$776K | 0.49% | 29 |
|
|
2015
Q3 | $9.09M | Sell |
97,365
-2,998
| -3% | -$290K | 0.47% | 31 |
|
|
2015
Q2 | $9.78M | Buy |
100,363
+300
| +0.3% | +$30K | 0.48% | 28 |
|
|
2015
Q1 | $10.1M | Hold |
100,063
| – | – | 0.48% | 27 |
|
|
2014
Q4 | $10.5M | Buy |
100,063
+150
| +0.2% | +$15.8K | 0.49% | 28 |
|
|
2014
Q3 | $10.7M | Sell |
99,913
-66
| -0.1% | -$6.84K | 0.6% | 24 |
|
|
2014
Q2 | $10.5M | Sell |
99,979
-942
| -0.9% | -$95.2K | 0.57% | 23 |
|
|
2014
Q1 | $9.91M | Sell |
100,921
-207
| -0.2% | -$19.2K | 0.54% | 23 |
|
|
2013
Q4 | $9.26M | Buy |
101,128
+1,775
| +2% | +$164K | 0.52% | 25 |
|
|
2013
Q3 | $8.61M | Buy |
99,353
+190
| +0.2% | +$17K | 0.5% | 26 |
|
|
2013
Q2 | $8.51M | Buy |
+99,163
| New | +$8.42M | 0.51% | 28 |
|
Other funds holding JNJ
Capital Counsel's JNJ Position: Q2 2022 in Review
Capital Counsel sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 339,630 shares — an estimated $60.2M sold.
Capital Counsel first reported a position in JNJ in Q2 2013 and held it in 36 quarters. The position peaked at $96.4M in Q2 2021. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.
- Capital Counsel reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
- Capital Counsel sold 339,630 Johnson & Johnson shares in Q2 2022, an estimated $60.2M.
- Capital Counsel first reported a position in Johnson & Johnson in Q2 2013 and held it in 36 quarters.
- Capital Counsel's Johnson & Johnson position peaked at $96.4M in Q2 2021.
- 3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.
Based on Capital Counsel's 13F filing for Q2 2022, filed 15 Aug 2022.